Hiyoshi, Hideyuki
Sakuma, Kensuke
Tsubooka-Yamazoe, Noriko
Asano, Shinya
Mochida, Taisuke
Yamaura, Junji
Konagaya, Shuhei
Fujii, Ryo
Matsumoto, Hirokazu
Ito, Ryo
Toyoda, Taro
Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
Received: 16 November 2021
Accepted: 11 March 2022
First Online: 18 March 2022
Competing interests
: T.T. is a scientific advisor of Orizuru Therapeutics. The remaining authors declare no competing interests.